SCHEMBL4341062

SCHEMBL4341062

CC1(C)CN(CC/C=C2/c3cc(O)ccc3OCc3ncccc32)CC[C@]1(O)c1ccc(Cl)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 10/20 0.81
▸ CHRM2 P08172 1/20 0.54
▸ CCR5 P51681 1/20 0.54
▸ HRH1 P35367 6/20 0.33
▸ ADRA1A P35348 2/20 0.32
▸ ADRA1D P25100 1/20 0.32
▸ ADRA1B P35368 1/20 0.32
▸ HTR2B P41595 2/20 0.31
▸ DRD4 P21917 1/20 0.31
▸ USP2 O75604 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ HTR1A P08908 1/20 0.31
▸ ADRA2A P08913 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ DRD2 P14416 1/20 0.31
▸ ADRA2B P18089 1/20 0.31
▸ ADRA2C P18825 1/20 0.31
▸ SLC6A2 P23975 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL652012 1.00 CCR1 (0.81) CCR1CHRM2CCR5HRH1ADRA1A
SCHEMBL652013 1.00 CCR1 (0.81) CCR1CHRM2CCR5HRH1ADRA1A
SCHEMBL4341064 1.00 CCR1 (0.81) CCR1CHRM2CCR5HRH1ADRA1A
SCHEMBL18776061 0.92 CCR1 (0.81) CCR1CHRM2CCR5HRH1ADRA1A
SCHEMBL18895909 0.91 CCR1 (0.80) CCR1CHRM2CCR5HRH1ADRA1A
SCHEMBL10287870 0.90 CCR1 (0.66) CCR1CHRM2CCR5HRH1ADRA1A
SCHEMBL438487 0.90 CCR1 (1.00) CCR1CHRM2CCR5HRH1
SCHEMBL2197331 0.90 CCR1 (0.77) CCR1CHRM2CCR5HRH1
SCHEMBL656424 0.90 CCR1 (0.77) CCR1CHRM2CCR5HRH1
SCHEMBL438265 0.90 CCR1 (1.00) CCR1CHRM2CCR5HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1448566-B3 CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF MILLENNIUM PHARM INC (US) 2009-04-08 — — EP disclosed
EP-1448566-B1 CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF MILLENNIUM PHARM INC (US) 2006-03-15 — — EP disclosed
Send feedback